Healthcare
GC Aesthetics enhanced with $60m investment
GC Aesthetics, a Dublin-based plastic surgery business, has secured a $60m investment from a consortium of investors.
Rosetta leads CHF 60m round for Novimmune
Life sciences-focused Rosetta Capital has led a CHF 60m ($66m) series-B funding round for Swiss biotech Novimmune.
HBM leads €41m round for AAA
HBM Healthcare Investments has led a €41m funding round for Advanced Accelerator Applications (AAA), a French biopharma company specialising in molecular nuclear medicine.
Deal in focus: uniQure raises $91.8m in IPO
Netherlands-based uniQure’s debut on the Nasdaq marks one of the latest in a string of European venture capital-backed biotechs flocking to the US markets, but the lack of activity in Europe's public markets does not necessarily equate to a slowdown in...
North West Fund backs Fusion Implants
The North West Fund for Venture Capital, managed by Enterprise Ventures, has made a six-figure capital commitment to Fusion Implants, which manufactures veterinary implants using 3D printing technology.
Epidarex leads £4m investment in EMI
Epidarex Capital (formerly Rock Spring Ventures) has taken part in a ТЃ4m series-A funding round for Edinburgh University spinout Edinburgh Molecular Imaging (EMI).
VC-backed Egalet raises $50.4m in IPO
VC-backed UK pharma Egalet has raised $50.4m in its IPO on the Nasdaq, giving the company a market cap of $166.8m.
VC-backed Circassia to float on LSE
Circassia, a UK allergy treatment developer backed by several investors, has announced its plans to float on the London Stock Exchange (LSE) next month.
BerGenBio secures further NOK 75m
Norwegian oncology biopharma BerGenBio has raised a further NOK 75m (approximately $12.5m) from a syndicate of new and existing investors.
VC-backed uniQure raises $91.8m in IPO
Venture capital-backed Dutch gene therapy company uniQure raised well above its original expectation in its listing on the Nasdaq, bagging $91.8m.
PBM acquires Breas Medical
Healthcare-focused investor PBM Capital has acquired Breas Medical, a Sweden-based developer of sleep apnea treatment products, from General Electric subsidiary GE Healthcare.
VIYM invests in Semeiny Doktor
Russian firm Venture Investments & Yield Management (VIYM) has acquired a significant stake in Semeiny Doktor, a Russian chain of family medical clinics.
VC-backed Crossject to list on NYSE Alternext
French medical device company Crossject, backed by a consortium of local venture capital firms, is hoping to raise up to €12.9m in its IPO on the NYSE Alternext Paris.
Mobeus invests £3.5m in Bourn
Mobeus Equity Partners has made an investment of ТЃ3.5m in Bourn Bioscience, a UK-based operator of in-vitro fertilisation (IVF) clinics that trades under the name Bourn Hall Clinic.
Montagu acquires Rexam divisions for $805m
Montagu Private Equity has acquired the healthcare devices and prescription retail divisions of UK consumer packaging company Rexam for $805m in cash.
VC-backed Egalet files $45.5m IPO
UK-based pharma company Egalet, backed by a consortium of venture capital firms, is seeking to raise up to $45.5m in its IPO on the Nasdaq.
Hutton Collins injects €50m into Dedalus
Hutton Collins has made a €50m investment in Dedalus, an Italian healthcare IT systems provider, along with a further €15m from co-investors.
IK's Attendo rumoured to list this year
IK Investment Partners could list Swedish elderly care provider Attendo on the Stockholm exchange this year, according to media reports.
Octopus supports Michelson Diagnostics
Octopus Investments has led a ТЃ1.98m round for existing portfolio company Michelson Diagnostics, a UK-based medical devices company.
VC-backed Lombard to leave AIM for Nasdaq
Lombard Medical Technologies, a London-based medical devices company backed by Abingworth Management and MVM Life Science Partners, is planning to delist from the London Stock Exchangeтs AIM and relist on the Nasdaq.
Deal in focus: VC-backed Okapi sold to US biopharma Aratana
The sale of venture-backed Belgian biopharmaceutical company Okapi Sciences to listed US biopharma Aratana Therapeutics highlights the benefits that come from maintaining relationships with former fellow investors.
Erhvervsinvest backs Scanbur
Erhvervsinvest has invested in Danish life sciences company Scanbur.
Gilde acquires Viroclinics
Gilde Healthcare Services has acquired a majority stake in Viroclinics Biosciences, a Netherlands-based virology contact research organisation (CRO).
VC-backed Okapi acquired by US biopharma Aratana
Belgian biopharmaceutical company Okapi Sciences, backed by several venture capital firms, has been acquired by listed US biopharma Aratana Therapeutics for a total consideration of up to €33.3m.